Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5502
-0.0346 (-5.92%)
Aug 11, 2025, 2:08 PM - Market open

Impact BioMedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
717----
Upgrade
Enterprise Value
1425----
Upgrade
Last Close Price
0.581.45----
Upgrade
PB Ratio
1.872.31----
Upgrade
Debt / Equity Ratio
1.341.230.430.310.310.03
Upgrade
Asset Turnover
---0.00--
Upgrade
Quick Ratio
0.130.200.0100.000.07
Upgrade
Current Ratio
0.220.250.030.010.020.10
Upgrade
Return on Equity (ROE)
-147.03%-139.55%-14.46%-19.99%-4.52%-3.89%
Upgrade
Return on Assets (ROA)
-7.06%-6.54%-5.53%-4.13%-3.81%-2.32%
Upgrade
Return on Capital (ROIC)
-8.12%-7.52%-6.07%-4.47%-4.18%-2.61%
Upgrade
Earnings Yield
-376.31%-148.12%----
Upgrade
FCF Yield
-61.97%-23.49%----
Upgrade
Buyback Yield / Dilution
75.02%82.14%14.54%0.00%--
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q